"Sulfadoxine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Descriptor ID |
D013413
|
MeSH Number(s) |
D02.065.884.725.765 D02.092.146.807.765 D02.886.590.700.725.765
|
Concept/Terms |
Sulfadoxine- Sulfadoxine
- Sulphormetoxin
- Sulphorthodimethoxine
- Sulformetoxine
- Sulformethoxine
- Sulforthomidine
|
Below are MeSH descriptors whose meaning is more general than "Sulfadoxine".
Below are MeSH descriptors whose meaning is more specific than "Sulfadoxine".
This graph shows the total number of publications written about "Sulfadoxine" by people in this website by year, and whether "Sulfadoxine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sulfadoxine" by people in Profiles.
-
Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020. Am J Trop Med Hyg. 2023 06 07; 108(6):1140-1144.
-
CLINICAL DECISIONS. Skin Abscess. N Engl J Med. 2016 Mar 03; 374(9):882-4.
-
A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg. 1998 Jan-Feb; 92(1):73-6.
-
Use of preventive interventions by persons infected with type-1 human immunodeficiency virus (HIV-1). The Pulmonary Complications of HIV Study Group. Am J Prev Med. 1994 Sep-Oct; 10(5):259-66.
-
Treatment of malaria with sulfadoxine/pyrimethamine: note of caution. Lancet. 1990 Jul 14; 336(8707):111-2.
-
An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica. 1989; 178(1):39-42.